Smooth Muscle Cells Influence Monocyte Response to LDL as well as Their Adhesion and Transmigration in a Coculture Model of the Arterial Wall
暂无分享,去创建一个
C. Remacle | Y. Schneider | P. V. Van Veldhoven | K. Jaworski | P. Holvoet | A. Trouet | F. Kinard | T. Sergent-Engelen | D. Goldstein
[1] P. Groot,et al. Chemokines and atherosclerosis. , 1999, Atherosclerosis.
[2] R. Stevens,et al. Endothelial cells inhibit smooth muscle cell secretion of hyaluronanic acid. , 1998, Journal of vascular surgery.
[3] H. Itabe. Oxidized phospholipids as a new landmark in atherosclerosis. , 1998, Progress in lipid research.
[4] O. Wiklund,et al. Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. , 1998, Atherosclerosis.
[5] B. Sumpio,et al. Coculture conditions alter endothelial modulation of TGF-beta 1 activation and smooth muscle growth morphology. , 1998, The American journal of physiology.
[6] B. Sumpio,et al. Coculture conditions alter endothelial modulation of TGF-β1 activation and smooth muscle growth morphology. , 1998, American journal of physiology. Heart and circulatory physiology.
[7] B. Rollins,et al. In vivo properties of monocyte chemoattractant protein‐1 , 1997, Journal of leukocyte biology.
[8] A. Roach,et al. Chemokine production by human vascular smooth muscle cells: modulation by IL‐13 , 1997, British journal of pharmacology.
[9] P. Tsao,et al. Nitric oxide regulates monocyte chemotactic protein-1. , 1997, Circulation.
[10] G. Rao,et al. Oxidized low density lipoprotein acts on endothelial cells in culture to enhance endothelin secretion and monocyte migration. , 1997, Methods and findings in experimental and clinical pharmacology.
[11] B. Sumpio,et al. Endothelial cell effect on smooth muscle cell collagen synthesis. , 1997, The Journal of surgical research.
[12] Yves-Jacques Schneider,et al. Compartmentalized coculture of porcine arterial endothelial and smooth muscle cells on a microporous membrane , 1997, In Vitro Cellular & Developmental Biology - Animal.
[13] P. Howe,et al. Oxidized Low Density Lipoprotein and Lysophosphatidylcholine Stimulate Cell Cycle Entry in Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.
[14] B. Sumpio,et al. Matrix-specific effect of endothelial control of smooth muscle cell migration. , 1996, Journal of vascular surgery.
[15] B. Rollins. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. , 1996, Molecular medicine today.
[16] H. Maegawa,et al. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. , 1996, Metabolism: clinical and experimental.
[17] N. Leitinger,et al. The effect of NO/EDRF and monocytes/macrophages on LDL-oxidation. , 1995, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[18] C. Cowan,et al. Lysophosphatidylcholine inhibits relaxation of rabbit abdominal aorta mediated by endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor independent of protein kinase C activation. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[19] G. Randolph,et al. A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. , 1995, Journal of immunology.
[20] J. Joseph,et al. Inhibition of macrophage-dependent low density lipoprotein oxidation by nitric-oxide donors. , 1995, Journal of lipid research.
[21] R. Busse,et al. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. , 1995, Circulation research.
[22] U. Ikeda,et al. Suppressive role of endogenous endothelial monocyte chemoattractant protein-1 on monocyte transendothelial migration in vitro. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[23] T. Sasaki,et al. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. , 1994, The Journal of biological chemistry.
[24] K. Kugiyama,et al. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation. , 1994, The American journal of physiology.
[25] M. Currie,et al. A fluorometric assay for the measurement of nitrite in biological samples. , 1993, Analytical biochemistry.
[26] M. Cybulsky,et al. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.
[27] S. Parthasarathy,et al. Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C. , 1991, Biochimica et biophysica acta.
[28] F. Parhami,et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[29] K. Hirata,et al. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. , 1990, Biochemical and biophysical research communications.
[30] M. Territo,et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. , 1990, The Journal of clinical investigation.
[31] Y. Schneider,et al. Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined, serum- and protein-free culture medium. , 1989, Journal of immunological methods.
[32] D. Steinberg,et al. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Bell,et al. Effect of harvesting methods, growth conditions and growth phase on diacylglycerol levels in cultured human adherent cells. , 1988, Biochimica et biophysica acta.
[34] U. Steinbrecher,et al. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. , 1987, The Journal of biological chemistry.
[35] P. Veldhoven,et al. Inorganic and organic phosphate measurements in the nanomolar range. , 1987, Analytical biochemistry.
[36] P. Davies. Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[37] Yagi Kunio,et al. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia , 1981 .
[38] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[39] Romanov IuA,et al. [Induction of cell adhesion molecules, E-selectin, VCAM-1 and ICAM-1, in a co-culture of human endothelial and smooth muscle cells]. , 1998 .
[40] J. Campbell,et al. Endothelial cell influences on vascular smooth muscle phenotype. , 1986, Annual review of physiology.
[41] K. Yagi,et al. Lipid peroxide levels and lipids content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia. , 1981, Clinica chimica acta; international journal of clinical chemistry.
[42] S. Aust,et al. Microsomal lipid peroxidation. , 1978, Methods in enzymology.